搜索临床试验以：EGFR-TKI
总计1825个结果
-
Cancer Institute and Hospital, Chinese Academy...未知非小细胞肺癌 | III 期非小细胞肺癌 | EGFR突变相关肿瘤
-
Yongchang ZhangJiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.完全的
-
Ahon Pharmaceutical Co., Ltd.Cancer Institute and Hospital, Chinese Academy of Medical Sciences未知
-
Shanghai Pulmonary Hospital, Shanghai, China未知非小细胞肺癌 | 表皮生长因子受体基因突变
-
Peking University3D Medicines; Hangzhou DIAN Medical Diagnostic Center Co., Ltd., China主动，不招人胃癌 | 大肠癌 | 胰腺癌 | 胃肠道间质瘤 | 神经内分泌肿瘤 | 食管鳞状细胞癌 | 胆道肿瘤 | 不明原发癌 | 消化道癌中国
-
The Fourth Affiliated Hospital of Zhejiang University...完全的
-
First Hospital of Shijiazhuang CityTianjin Hengjia Biotechnology Development co., LTD未知
-
University Hospital, Bordeaux招聘中在使用 PD1/PDL1 ICIs + VEGFR-酪氨酸激酶抑制剂治疗 12 个月时有客观反应的 mRCC 患者中只有一个不良预后因素的 IMDC 良好或中等风险的治疗暂停与治疗继续 (SPICI)转移性肾细胞癌 | 每个 IMDC 评分的良好或只有一个不良预后因素中等风险法国
-
City of Hope Medical CenterNational Cancer Institute (NCI)主动，不招人
-
Tian XieLinkDoc Technology (Beijing) Co. Ltd.招聘中
-
Shenzhen People's Hospital未知
-
Shanghai Chest HospitalChanghai Hospital; Ruijin Hospital未知
-
RenJi HospitalShanghai Zhongshan Hospital; Ruijin Hospital招聘中
-
Tongji HospitalWuhan University; Hubei Cancer Hospital; Wuhan Union Hospital, China; Renmin Hospital of Wuhan University完全的
-
Fujian Cancer Hospital尚未招聘
-
Sichuan Cancer Hospital and Research InstituteJiangsu HengRui Medicine Co., Ltd.未知
-
AstraZeneca完全的
-
Second Affiliated Hospital of Guangzhou Medical...招聘中
-
Spanish Lung Cancer Group完全的
-
Tata Memorial Hospital招聘中
-
Chinese PLA General Hospital招聘中
-
Chinese PLA General Hospital未知
-
Zhejiang University未知